EUVIMEDEUVIMED entdecken
Crossref

Perspectives of preimplantation genetic testing patients in Belgium on the ethics of polygenic embryo screening

Maria Siermann, Joris R Vermeesch, Taneli Raivio, Arne Vanhie, Karen Peeraer, Olga Tšuiko, Pascal Borry

Reproductive BioMedicine Online · 2024

DOI: 10.1016/j.rbmo.2024.104294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2024. Verfasst von Maria Siermann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Physiology, Faculty of …. Hauptthemen laut MEDLINE: Preimplantation Diagnosis, Genetic Testing. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: European Union's Horizon 2020 research and innovation programme under Marie Skłodowska-Curie grant agreement, Horizon 2020, H2020 Marie Skłodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: What are the perspectives of preimplantation genetic testing (PGT) patients in Belgium on the ethics of PGT for polygenic risk scoring (PGT-P)? DESIGN: In-depth interviews (18 in total, 10 couples, 8 women, n = 28) were performed with patients who had undergone treatment with PGT for monogenic/single-gene defects (PGT-M) or chromosomal structural rearrangements (PGT-SR) between 2017 and 2019 in Belgium. Participants were asked about their own experiences with PGT-M/SR and about their viewpoints on PGT-P, including their own interest and their ideas on its desirability, scope and consequences. Inductive content analysis was used to analyse the interviews. RESULTS: Participants stated that their experiences with PGT-M/SR had been physically, psychologically and practically difficult. Most participants stated that, partly because of these difficulties, they did not see the added value of knowing the risk scores of embryos via PGT-P. Many participants worried that PGT-P could lead to additional anxieties, responsibilities and complex choices in reproduction and parenthood. They argued that not everything should be controlled and felt that PGT-P, especially non-medical and broad screening, was going too far. With regards to the clinical implementation of PGT-P, participants in general preferred PGT-P to be limited to people with a serious polygenic family history and wanted embryo selection decisions to be made by healthcare professionals. CONCLUSIONS: This study shows that individuals with experience of PGT-M/SR saw PGT-P as different from PGT-M/SR. They had various ethical concerns with regards to PGT-P, especially regarding broadly offering PGT-P. These stakeholder viewpoints need to be considered regarding potential PGT-P implementation and guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Preimplantation DiagnosisGenetic TestingHumansFemaleBelgiumAdultMaleMultifactorial InheritancePregnancy

Stichwörter der Autor:innen

EthicsPatient perspectivesPolygenic embryo screeningPolygenic risk scoresPreimplantation genetic testingQualitative research

Autor:innen und Institutionen

  • Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic addres…
  • Laboratory for Cytogenetics and Genome Research, Department of Human Genetics, KU Leuven, Leuven, Belgium.
  • Department of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Leuven University Fertility Centre, Department of Gynaecology and Obstetrics, University Hospital Leuven, Leuven, Belgium; Laboratory of Endometrium, Endometriosis and Reproductive Medicine (LEERM), Department of Develo…
  • Reproductive Genetics Unit, Center for Human Genetics, University Hospital Leuven, Leuven, Belgium.
  • Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Förderung

  • European Union's Horizon 2020 research and innovation programme under Marie Skłodowska-Curie grant agreement
  • Horizon 2020
  • H2020 Marie Skłodowska-Curie Actions

Zitieren

APA

Siermann, M., Vermeesch, J. R., Raivio, T., Vanhie, A., Peeraer, K., Tšuiko, O., & Borry, P. (2024). Perspectives of preimplantation genetic testing patients in Belgium on the ethics of polygenic embryo screening. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2024.104294

Vancouver

Siermann M, Vermeesch JR, Raivio T, Vanhie A, Peeraer K, Tšuiko O, et al. Perspectives of preimplantation genetic testing patients in Belgium on the ethics of polygenic embryo screening. Reproductive BioMedicine Online. 2024. doi:10.1016/j.rbmo.2024.104294

BibTeX
@article{Siermann2024,
  author = {Siermann, Maria and Vermeesch, Joris R and Raivio, Taneli and Vanhie, Arne and Peeraer, Karen and Tšuiko, Olga and Borry, Pascal},
  title = {Perspectives of preimplantation genetic testing patients in Belgium on the ethics of polygenic embryo screening},
  journal = {Reproductive BioMedicine Online},
  year = {2024},
  doi = {10.1016/j.rbmo.2024.104294}
}
Kostenlos starten →